Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadFlagellin as carrier and adjuvant in cocaine vaccine development.Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species.Utilizing bacterial flagellins against infectious diseases and cancers.Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.Polymannuronic acid ameliorated obesity and inflammation associated with a high-fat and high-sucrose diet by modulating the gut microbiome in a murine model.Synthetically defined glycoprotein vaccines: current status and future directions.Vaccine strategies against cystic fibrosis pathogens.Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia.Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.A scalable method for biochemical purification of Salmonella flagellin.Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine.Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.Acceptor reactivity in the total synthesis of alginate fragments containing α-L-guluronic acid and β-D-mannuronic acid.Potential targets for next generation anti-microbial glycoconjugate vaccines.Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
P2860
Q26852817-644CF951-547E-4B5A-AF73-6E891E5A3D57Q35057556-6A44147D-535E-4633-809D-A990F9299141Q35891241-861F5C40-FBC1-4E8B-9864-13C85C19814AQ38166277-77876886-BE03-4CDA-A1CB-0EEA9A2934DAQ38210319-3D5E557E-EE98-49BD-AC2B-A90DAD9DCBC3Q38772647-360F6ABC-F5C9-41CB-A03B-ED43DF4A0588Q39375701-F82E57F2-F843-43A0-93D3-E40BA79862BCQ40262035-BF226F59-8CEE-44AB-B81F-361908078C7DQ40267074-99193FA1-5172-4447-992B-028EF5C2C359Q40284594-7B22E3D3-E54B-474E-8804-0C85483F7DA0Q41620789-4F5A75B7-E838-44B5-9FD9-0626A07ECB56Q42915324-DDF318E5-638B-4B55-A9B8-822ED196DC82Q43454357-94497507-4977-4041-AB38-C8878595878BQ43954962-3ED575AC-B2D8-4B58-B3E2-45D3A90748EFQ45174642-617B49D2-97B9-4D18-8ED8-25B3E4E1FCBBQ53511361-FADA3509-99DC-4866-9AA1-E01D82D29E34Q53701548-E57F1764-6722-4506-8D1B-9F0474140C02Q58762161-156CDDD3-A7AA-4FCD-9426-672D70A0017A
P2860
Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@ast
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@en
type
label
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@ast
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@en
prefLabel
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@ast
Efficacy of a conjugate vaccin ...... ginosa lung infection in mice.
@en
P2093
P2860
P356
P1476
Efficacy of a conjugate vaccin ...... uginosa lung infection in mice
@en
P2093
Leticia V Bentancor
Nicolas J Llosa
Tomas Maira-Litran
Victoria L Campodónico
P2860
P304
P356
10.1128/IAI.00157-11
P407
P50
P577
2011-05-31T00:00:00Z